Robert Duggan, Chairman & CEO, Director, Ten Percent Owner at Pharmacyclics, holds 48.60M shares in Pulse Biosciences (Ticker: PLSE), holds 587.43M shares in Summit Therapeutics (Ticker: SMMT), holds 5.76M shares in Achaogen (Ticker: AKAOQ). Most recently, Robert Duggan Bought ― shares of Pulse Biosciences on Dec 18, 2024 for an estimated value of 58.37M.
What is the percentage of profitable transactions made by Robert Duggan?
The percentage of profitable transactions made by Robert Duggan is 38%.
What is the average return per transaction made by Robert Duggan?
The average return per transaction made by Robert Duggan is -3.20%.
What stocks does Robert Duggan hold?
Robert Duggan holds: PCYC, PLSE, AKAOQ, SMMT, ISRG stocks.
What was Robert Duggan’s latest transaction?
Robert Duggan latest transaction was an Informative Buy of $58.37M.
What was Robert Duggan's most profitable transaction?
Robert Duggan’s most profitable transaction was an Informative Buy of SMMT stock on March 8, 2023. The return on the trade was 189.40%.
What is Robert Duggan's role in Pharmacyclics?
Robert Duggan's role in Pharmacyclics is Chairman & CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.